Chiesi Canada Corp clinical trials
A country office of Chiesi Farmaceutici S.p.A.
The registry lists 2 studies whose lead sponsor is Chiesi Canada Corp. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Mar 15, 2024.
Registry sponsor names on this page
- Chiesi Canada Corp2 studies
Something wrong with this grouping? Tell us on the Chiesi Farmaceutici S.p.A. page.
Studies
Recruiting first, then most recently updated. Showing 2 of 2. All Chiesi Farmaceutici S.p.A. studies →
- Safety and Efficacy of Early Treatment With Deferiprone in Infants and Young ChildrenCompletedNCT03591575Phase 4
Sponsor listed in the registry: Chiesi Canada Corp
- Compassionate Use of Deferiprone in Patients With PKANNo longer availableNCT02635841
Sponsor listed in the registry: Chiesi Canada Corp